Skip to main content
. Author manuscript; available in PMC: 2014 Apr 21.
Published in final edited form as: J Investig Med. 2010 Dec;58(8):945–949. doi: 10.231/JIM.0b013e3181fb7ca7

Table 2.

Cross tabulation of year 2000 samples based on C-LDL-C and D-LDL-C at clinically meaningful LDL-C treatment goals. Numbers along the diagonal of the table (in bold) indicate where the measures agree. Numbers in the off-diagonal cells indicate some level of disagreement.

C-LDL-C D-LDL-C Treatment Goal (mg/dl)
Treatment
Goal (mg/dl)
<70 70 – 100 100 – 130 130 – 160 ≥ 160 Total
<70 2 19 3 4 0 28
70 – 100 0 44 50 5 2 101
100 – 130 0 2 96 50 1 149
130 – 160 0 0 2 91 20 113
≥ 160 0 0 0 7 66 73
Total 2 65 151 157 89 464

Kappa Statistic: 0.5272 (0.4703, 0.5841)

Generalized McNemar Test: p < 0.001

HHS Vulnerability Disclosure